Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Thalidomide-NH-PEG4-Ms is a conjugate that consists of a cereblon ligand based on Thalidomide and a linker molecule, which serves as a ligand-linker moiety for E3 ligase. This conjugate is specifically designed as a degrader for PROTAC BCL-XL, known as XZ739.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Thalidomide-NH-PEG4-Ms is a conjugate that consists of a cereblon ligand based on Thalidomide and a linker molecule, which serves as a ligand-linker moiety for E3 ligase. This conjugate is specifically designed as a degrader for PROTAC BCL-XL, known as XZ739. |
In vitro | XZ739, functioning as a CRBN-dependent PROTAC BCL-XL degrader, exhibits a potent activity with a DC50 of 2.5 nM in MOLT-4 cells, post a 16-hour exposure. Additionally, it promotes caspase-mediated apoptosis, leading to cell death[1]. |
Synonyms | Thalidomide-NH-PEG4-Ms |
Molecular Weight | 527.55 |
Formula | C22H29N3O10S |
CAS No. | 2140807-24-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Thalidomide-NH-PEG4-Ms 2140807-24-3 Thalidomide NH PEG4 Ms ThalidomideNHPEG4Ms Thalidomide-NH-PEG-4-Ms inhibitor inhibit